Regen Medicine Prepares for Growth Spurt - Novel Business Models, Emerging Players, and Transformative Products Starting to Have Impact

Scientia Advisors' analyst, Michael Tapella, and partner, Arshad Ahmed, are featured in the November 1st, 2010 issue of Genetic Engineering & Biotechnology News with an article titled: "Regen Medicine Prepares for Growth Spurt - Novel Business Models, Emerging Players, and Transformative Products Starting to Have Impact"

The regenerative medicine industry is likely to change over the next 10+ years as numerous novel cell-based therapies enter the market and address unmet medical needs. If some of these therapies reach their promise, we are likely to see dramatic changes in the management and treatment of certain chronic diseases and significantly lower overall healthcare costs. These innovations have considerable implications for traditional players in the pharmaceutical and medical-device industries -particularly regarding current business models and market approaches.

The article can be accessed on the Genetic Engineering & Biotechnology News website here.